Invention Grant
- Patent Title: Compounds and methods for delivery of prostacyclin analogs
-
Application No.: US17495141Application Date: 2021-10-06
-
Publication No.: US11292758B2Publication Date: 2022-04-05
- Inventor: Ken Phares
- Applicant: United Therapeutics Corporation
- Applicant Address: US MD Silver Spring
- Assignee: United Therapeutics Corporation
- Current Assignee: United Therapeutics Corporation
- Current Assignee Address: US MD Silver Spring
- Agency: Foley & Lardner LLP
- Main IPC: C07C59/13
- IPC: C07C59/13 ; C07C59/70 ; C07C229/08 ; C07C235/06 ; C07C235/08 ; C07C259/06 ; C07F9/09 ; C07F9/117 ; C07C69/712 ; C07C51/41 ; A61K31/235 ; A61K9/00 ; A61K31/192 ; A61K31/216 ; A61K31/223
Abstract:
This invention pertains generally to prostacyclin formulations and methods for their use in promoting vasodilation, inhibiting platelet aggregation and thrombus formation, stimulating thrombolysis, inhibiting cell proliferation (including vascular remodeling), providing cytoprotection, preventing atherogenesis and inducing angiogenesis.
Public/Granted literature
- US20220024845A1 COMPOUNDS AND METHODS FOR DELIVERY OF PROSTACYCLIN ANALOGS Public/Granted day:2022-01-27
Information query
